Department of Clinical Analysis, Toxicology and Bromatology, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
J Cell Mol Med. 2013 Dec;17(12):1554-65. doi: 10.1111/jcmm.12118. Epub 2013 Nov 1.
Insufficient oxygen delivery to organs leads to tissue dysfunction and cell death. Reperfusion, although vital to organ survival, initiates an inflammatory response that may both aggravate local tissue injury and elicit remote organ damage. Polymorphonuclear neutrophil (PMN) trafficking to remote organs following ischaemia/reperfusion (I/R) is associated with the release of lipid mediators, including leucotriene (LT) B4 , cysteinyl-LTs (CysLTs) and platelet-activating factor (PAF). Yet, their potentially cooperative role in regulating I/R-mediated inflammation has not been thoroughly assessed. The present study aimed to determine the cooperative role of lipid mediators in regulating PMN migration, tissue oedema and injury using selective receptor antagonists in selected models of I/R and dermal inflammation. Our results show that rabbits, pre-treated orally with BIIL 284 and/or WEB 2086 and MK-0571, were protected from remote tissue injury following I/R or dermal inflammation in an additive or synergistic manner when the animals were pre-treated with two drugs concomitantly. The functional selectivity of the antagonists towards their respective agonists was assessed in vitro, showing that neither BIIL 284 nor WEB 2086 prevented the inflammatory response to IL-8, C5a and zymosan-activated plasma stimulation. However, these agonists elicited LTB4 biosynthesis in isolated rabbit PMNs. Similarly, a cardioprotective effect of PAF and LTB4 receptor antagonists was shown following myocardial I/R in mice. Taken together, these results underscore the intricate involvement of LTB4 and PAF in each other's responses and provide further evidence that targeting both LTs and PAF receptors provides a much stronger anti-inflammatory effect, regulating PMN migration and oedema formation.
器官供氧不足会导致组织功能障碍和细胞死亡。再灌注虽然对器官存活至关重要,但会引发炎症反应,既可能加重局部组织损伤,又可能引发远处器官损伤。缺血/再灌注(I/R)后多形核中性粒细胞(PMN)向远处器官的迁移与脂质介质的释放有关,包括白三烯(LT)B4、半胱氨酰-LTs(CysLTs)和血小板激活因子(PAF)。然而,它们在调节 I/R 介导的炎症中的潜在协同作用尚未得到充分评估。本研究旨在使用选择性受体拮抗剂,在 I/R 和皮肤炎症的选定模型中,确定脂质介质在调节 PMN 迁移、组织水肿和损伤方面的协同作用。我们的研究结果表明,兔预先经口给予 BIIL 284 和/或 WEB 2086 和 MK-0571 预处理,可在 I/R 或皮肤炎症后以累加或协同方式,防止远处组织损伤。拮抗剂对各自激动剂的功能选择性在体外进行评估,结果表明,BIIL 284 和 WEB 2086 均不能预防 IL-8、C5a 和酵母聚糖激活的血浆刺激引起的炎症反应。然而,这些激动剂在分离的兔 PMN 中诱发 LTB4 生物合成。同样,在小鼠心肌 I/R 后也显示 PAF 和 LTB4 受体拮抗剂具有心脏保护作用。综上所述,这些结果强调了 LTB4 和 PAF 在彼此反应中的复杂参与,并进一步证明靶向 LT 和 PAF 受体可提供更强的抗炎作用,调节 PMN 迁移和水肿形成。